Cargando…
c-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors
BACKGROUND: Peripheral T-cell lymphomas (PTCLs) are often aggressive tumors and resistant to conventional chemotherapy. Dysregulation of extrinsic apoptosis plays an important role on tumor cell sensitivity to chemotherapeutic agents. Cellular FLICE inhibitory protein (c-FLIP) is a key regulator of...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261569/ https://www.ncbi.nlm.nih.gov/pubmed/25477070 http://dx.doi.org/10.1186/s13045-014-0088-y |
_version_ | 1782348294846939136 |
---|---|
author | Zheng, Zhong Cheng, Shu Wu, Wen Wang, Li Zhao, Yan Shen, Yang Janin, Anne Zhao, Wei-Li |
author_facet | Zheng, Zhong Cheng, Shu Wu, Wen Wang, Li Zhao, Yan Shen, Yang Janin, Anne Zhao, Wei-Li |
author_sort | Zheng, Zhong |
collection | PubMed |
description | BACKGROUND: Peripheral T-cell lymphomas (PTCLs) are often aggressive tumors and resistant to conventional chemotherapy. Dysregulation of extrinsic apoptosis plays an important role on tumor cell sensitivity to chemotherapeutic agents. Cellular FLICE inhibitory protein (c-FLIP) is a key regulator of extrinsic apoptotic pathway. METHODS: c-FLIP expression was assessed by real-time PCR and compared according to clinical parameters in patients with PTCLs. The relation of c-FLIP to tumor cell apoptosis mediated by histone deacetylases inhibitors (HDACIs) and the possible mechanism were examined in T-lymphoma cell lines and in a murine xenograft model. RESULTS: c-FLIP was overexpressed and associated with decreased tumor TRAIL/DR5 expression, elevated serum lactate dehydrogenase level and high-risk International Prognostic Index of the patients. In vitro, molecular silencing of c-FLIP by specific small-interfering RNA increased TRAIL/DR5 expression, enhanced T-lymphoma cell apoptosis and sensitized cells to chemotherapeutic agents. However, HDACIs valproic acid (VPA) and suberoylanilide hydroxamic acid (SAHA) could downregulate c-FLIP expression and triggered extrinsic apoptosis of T-lymphoma cells, through inhibiting NF-κB signaling and interrupting P50 interaction with c-FLIP promoter. As Class I HDACIs, both VPA and SAHA inhibited HDAC1, resulting in P50 inactivation and c-FLIP downregulation. In vivo, oral VPA treatment significantly retarded tumor growth and induced in situ apoptosis, consistent with inhibition of HDAC1/P50/c-FLIP axis and increase of TRAIL/DR5 expression. CONCLUSIONS: c-FLIP overexpression in PTCLs protected tumor cells from extrinsic apoptosis and contributed to tumor progression. Although linking to chemoresistance, c-FLIP indicated tumor cell sensitivity to HDACIs, providing a potential biomarker of targeting apoptosis in treating PTCLs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13045-014-0088-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4261569 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42615692014-12-10 c-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors Zheng, Zhong Cheng, Shu Wu, Wen Wang, Li Zhao, Yan Shen, Yang Janin, Anne Zhao, Wei-Li J Hematol Oncol Research BACKGROUND: Peripheral T-cell lymphomas (PTCLs) are often aggressive tumors and resistant to conventional chemotherapy. Dysregulation of extrinsic apoptosis plays an important role on tumor cell sensitivity to chemotherapeutic agents. Cellular FLICE inhibitory protein (c-FLIP) is a key regulator of extrinsic apoptotic pathway. METHODS: c-FLIP expression was assessed by real-time PCR and compared according to clinical parameters in patients with PTCLs. The relation of c-FLIP to tumor cell apoptosis mediated by histone deacetylases inhibitors (HDACIs) and the possible mechanism were examined in T-lymphoma cell lines and in a murine xenograft model. RESULTS: c-FLIP was overexpressed and associated with decreased tumor TRAIL/DR5 expression, elevated serum lactate dehydrogenase level and high-risk International Prognostic Index of the patients. In vitro, molecular silencing of c-FLIP by specific small-interfering RNA increased TRAIL/DR5 expression, enhanced T-lymphoma cell apoptosis and sensitized cells to chemotherapeutic agents. However, HDACIs valproic acid (VPA) and suberoylanilide hydroxamic acid (SAHA) could downregulate c-FLIP expression and triggered extrinsic apoptosis of T-lymphoma cells, through inhibiting NF-κB signaling and interrupting P50 interaction with c-FLIP promoter. As Class I HDACIs, both VPA and SAHA inhibited HDAC1, resulting in P50 inactivation and c-FLIP downregulation. In vivo, oral VPA treatment significantly retarded tumor growth and induced in situ apoptosis, consistent with inhibition of HDAC1/P50/c-FLIP axis and increase of TRAIL/DR5 expression. CONCLUSIONS: c-FLIP overexpression in PTCLs protected tumor cells from extrinsic apoptosis and contributed to tumor progression. Although linking to chemoresistance, c-FLIP indicated tumor cell sensitivity to HDACIs, providing a potential biomarker of targeting apoptosis in treating PTCLs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13045-014-0088-y) contains supplementary material, which is available to authorized users. BioMed Central 2014-12-05 /pmc/articles/PMC4261569/ /pubmed/25477070 http://dx.doi.org/10.1186/s13045-014-0088-y Text en © Zheng et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Zheng, Zhong Cheng, Shu Wu, Wen Wang, Li Zhao, Yan Shen, Yang Janin, Anne Zhao, Wei-Li c-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors |
title | c-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors |
title_full | c-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors |
title_fullStr | c-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors |
title_full_unstemmed | c-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors |
title_short | c-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors |
title_sort | c-flip is involved in tumor progression of peripheral t-cell lymphoma and targeted by histone deacetylase inhibitors |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261569/ https://www.ncbi.nlm.nih.gov/pubmed/25477070 http://dx.doi.org/10.1186/s13045-014-0088-y |
work_keys_str_mv | AT zhengzhong cflipisinvolvedintumorprogressionofperipheraltcelllymphomaandtargetedbyhistonedeacetylaseinhibitors AT chengshu cflipisinvolvedintumorprogressionofperipheraltcelllymphomaandtargetedbyhistonedeacetylaseinhibitors AT wuwen cflipisinvolvedintumorprogressionofperipheraltcelllymphomaandtargetedbyhistonedeacetylaseinhibitors AT wangli cflipisinvolvedintumorprogressionofperipheraltcelllymphomaandtargetedbyhistonedeacetylaseinhibitors AT zhaoyan cflipisinvolvedintumorprogressionofperipheraltcelllymphomaandtargetedbyhistonedeacetylaseinhibitors AT shenyang cflipisinvolvedintumorprogressionofperipheraltcelllymphomaandtargetedbyhistonedeacetylaseinhibitors AT janinanne cflipisinvolvedintumorprogressionofperipheraltcelllymphomaandtargetedbyhistonedeacetylaseinhibitors AT zhaoweili cflipisinvolvedintumorprogressionofperipheraltcelllymphomaandtargetedbyhistonedeacetylaseinhibitors |